extramedullary disease (B-LBL) in 10% and B-ALL/B-LBL in 10% of incidence. [20] Extramedullary signs and symptoms when appear at the time of diagnosis determine and represent bone marrow involvement and often morphologically manifest or require identification by high-resolution flow cytometry. [20] case RepoRt A 17- year-old male presented dated August 17, 2016 (Patient ID: Apollo UHID 630068) in Apollo Hospitals Dhaka (Plot: 81, Block: E, Bashundhara R/A, Dhaka 1229, Bangladesh) with fever and itching, low back pain, neck pain, bilateral mild pleural effusion, urinary incontinence and progressive bilateral lower limb weakness for 3 weeks. There was no history of allergies, skin rash or parasitic infestation. On neurological examination, the Glasgow Coma Scale found E4V5M6, and he had no lymphadenopathy or organomegaly except bilateral pleural effusion. The magnetic resonance imaging of the whole spine showed a space-occupying lesion at epidural, opposite dorsal and sacral (D4-D8, and S1) vertebrae and dorsal cord compression at D5-D8 levels [ Figure 1 ]. Patient's the laboratory and biochemical data on admission depicted in Tables 1 and 2 . He underwent urgent decompressive laminectomy and debunking of the tumour mass, and high-dose steroid was given, which made the diagnosis difficult. High-dose steroid might reduce the blast percentage in bone marrow, and it was revealed a 20% blast when we do bone marrow aspiration after surgery. Peripheral blood film revealed high leukocyte count (26.34 × 10 9 ) with oeosinophil constituting 43.8%; AEC was 11. 53 × 109. No atypical cells or haemoparasites were seen [ Figure 2 ]. Bone marrow aspiration morphology showed cellular marrow with immature cells admixed with oeosinophils [ Figure 3 ]. Flow cytometry from bone marrow revealed blast cells 20%. Blast cells were positive for CD45, CD10, CD19, CD79a, CD34, human leukocyte antigen -DR isotype and terminal deoxynucleotidyl transferase (TdT) and negative for MPO, CD13, CD33 [ Figure 4 ] and immunohistochemistry from vertebral lesion and paravertebral mass positive for PAX5, TdT, CD79a, CD34 and CD45 and negative for Bcl6, CD5, CD7, CD20, MPO and Ki-67 was 40%. The bone marrow cytogenetic study was normal male pattern [ Figure 5 ]. Computed tomography scan of the chest exhibited bilateral pleural effusion probably due to oeosinophilic infiltration in the lungs and pleural cavity. Echocardiogram with the left ventricular ejection fraction of 55% and cerebrospinal fluid study was negative for malignant cells. The patient was relocated to the haematology ward for chemotherapy. Started BFM-95 pediatric inspired chemoprotocol. The condition of the patient improved after chemotherapy and trailed up for 2 years, and right now, the patient is effectively alleviated.
dIscussIon
The current patient had severe oeosinophilia. Oeosinophilia connected with ALL was first reported by Spitzer and Garson in 1973. [26] Two cases of ALL with oeosinophilia were reported by Parasole et al. [13] The median age at diagnosis is 14 years; male preponderance and the majority are B-cell origins. Patients regularly present with signs and symptoms of organ involvement due to infiltration of organs with oeosinophils. Heart, lungs, skin, central nervous system, liver and spleen are usually involved. Cough, shortness of breath, cardiomegaly and lung infiltrates often observed in one-third to two-thirds of patients. [19] Cytogenetic abnormalities are detected about half of the patients with ALL associated with hyperoeosinophilia. [19] The most common cytogenetic foible observed in patients with ALL related to oeosinophilia is t (5;14) (q31; q32). [15] The oeosinophilia is followed by overproduction of interleukin (IL)-3, IL-5 and granulocyte-stimulating factor by the blasts due to instigation of growth factor gene on chromosome 5 when it is translocated head-to-head to the immunoglobulin heavy chain gene on the chromosome. [2, 19] The chromosomal irregularity is typically seen only in leukaemic blasts, and the oeosinophils had normal karyotype in 90% of cases supportive of the hypothesis that the oeosinophilia is reactive. [16] The current patient had a normal karyotype. The current patient presented with severe oeosinophilia and organ involvement like skin rash and mild bilateral pleural effusion probably due to oeosinophilic infiltration. Oeosinophils secrete oeosinophil granulated proteins which are accountable for the cardiotoxic effects such as acute pericarditis, myocarditis or endocarditis, and the development of thrombi adjacent to the injured myocardium and succeeding fibrosis lead to restrictive heart failure. [17] One earlier study reported that 61-year-old male presented with signs of oeosinophilic toxicity including myocardial infarction, oeosinophilic pneumonia and urticaria subsequently was diagnosed to have B ALL. [18] Another study revealed that two patients with oeosinophilia related to ALL also developed myocardial infarction, respiratory failure and cerebrovascular accident as severe difficulties of oeosinophilia. [14] The prognosis of patients with ALL connected with hyperoeosinophilia is poor with a median survival of 7.5 months. [2] In a review of ALL associated with hyperoeosinophilia, 26% of deaths were oeosinophilia related. [19] Since anthracyclines are an essential component of chemotherapy for ALL, oeosinophilic infiltration of the heart and lungs could compromise the treatment. Oeosinophilia in the peripheral blood smear of patients with ALL/LBL has been reported more often than other types of leukaemia. [19] Most recently, Wilson and Tefferi [14] reported two cases of pre-B cell ALL that initially presented with prolonged oeosinophilia and respiratory distress. After a period, a diagnosis of leukaemia was made. Oeosinophilia usually leads to the diagnosis of ALL and rapidly resolves upon induction, but it typically returns with leukaemia reversion. The prognosis for ALL and hyperoeosinophilia is expressively shoddier than for ALL alone. In some reports, oeosinophilia preceded the ALL diagnosis by 1-9 months. [14, 27] Follows et al. reported on a 43-year old patient with 13,400/mm 3 oeosinophils in peripheral blood smear, who had a normal platelet count and haemoglobin level and subsequently developed migratory arthritis with periarticular soft-tissue swellings and hepatosplenomegaly. [28] This patient was finally diagnosed as an ALL case. In general, reported patients with significant oeosinophilia and ALL are adults. [28] However, Files et al. [29] reported on an 8-year-old male with hyperoeosinophilia and Loeffler endocarditis who was diagnosed with ALL after 3 months. In comparison to the standard definition of ALL, congestive heart failure is the leading cause of augmented mortality in patients with ALL with hyperoeosinophilia. [30] A literature review shows that among ALL cases, there is a sturdy male great in number, a median age of 14 years (range 2-58) at presentation, and most examples are B-cell in origin. [30] Multiple studies revealed that a major portion of the patients with ALL related with hyperoeosinophilia shows cytogenetic abnormalities and most common anomalies are t (5;14) (q31; q32), which is otherwise rare in ALL, but in the current patient, has normal karyotype. [19, [31] [32] [33] conclusIon Hyperoeosinophilia with ALL/LBL at diagnosis is very rare, particularly the absence of blast in peripheral blood might delay the diagnosis. Rarely, ALL/LBL is detected by oeosinophilia presenting with temperately amplified white blood cell and a higher percentage of oeosinophils. Hence, in patients with consistent hyperoeosinophilia with no influential reactive causes, bone marrow investigation is a must for an accurate diagnosis. It has been estimated of ALL/LBL presenting as hyperoeosinophilia is pointedly worse than ALL alone. Consequently, these patients need immediate diagnosis and intensive therapy.
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